Lv11
34 积分 2021-09-02 加入
Switching to camizestrant at ESR1 mutation emergence before disease progression during first-line treatment of hormone receptor-positive advanced breast cancer (SERENA-6): extended analysis of a double-blind, placebo-controlled, randomised, phase 3 trial
3小时前
已完结
A phase 1, open-label study evaluating the pharmacokinetics, safety, and tolerability of vepdegestrant in Chinese patients with ER+/HER2- advanced breast cancer
3小时前
已完结
Randomized Phase III Study of Amcenestrant Plus Palbociclib Versus Letrozole Plus Palbociclib in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Primary Results From AMEERA-5
3小时前
已完结
Elacestrant in Combination with Everolimus for Estrogen Receptor-Positive, HER2-Negative Previously Treated Advanced Breast Cancer: Results from ELEVATE
3小时前
已关闭
Constructing shared genetic architecture between bioavailable testosterone and luminal A breast cancer in female
3个月前
已完结
A retrospective comparative analysis of risk factors and outcomes in direct-to-implant and two-stages prepectoral breast reconstruction: BMI and radiotherapy as new selection criteria of patients
4个月前
已完结
Constructing shared genetic architecture between bioavailable testosterone and luminal A breast cancer in female
7个月前
已关闭
Novel insights into the causal relationship between endocrine-disrupting chemicals and breast cancer mediated by circulating metabolites
9个月前
已完结
Novel insights into the causal relationship between endocrine-disrupting chemicals and breast cancer mediated by circulating metabolites
9个月前
已完结
Genome-wide association study identified new susceptibility loci for polycystic ovary syndrome
11个月前
已完结
皖公网安备34019202002308
